![Trk-Receptor-Inhibitors-Modulators-MCE_第1页](http://file4.renrendoc.com/view/9ade6bead586c0e947df801d0b33d544/9ade6bead586c0e947df801d0b33d5441.gif)
![Trk-Receptor-Inhibitors-Modulators-MCE_第2页](http://file4.renrendoc.com/view/9ade6bead586c0e947df801d0b33d544/9ade6bead586c0e947df801d0b33d5442.gif)
![Trk-Receptor-Inhibitors-Modulators-MCE_第3页](http://file4.renrendoc.com/view/9ade6bead586c0e947df801d0b33d544/9ade6bead586c0e947df801d0b33d5443.gif)
![Trk-Receptor-Inhibitors-Modulators-MCE_第4页](http://file4.renrendoc.com/view/9ade6bead586c0e947df801d0b33d544/9ade6bead586c0e947df801d0b33d5444.gif)
![Trk-Receptor-Inhibitors-Modulators-MCE_第5页](http://file4.renrendoc.com/view/9ade6bead586c0e947df801d0b33d544/9ade6bead586c0e947df801d0b33d5445.gif)
Trk-Receptor-Inhibitors-Modulators-MCE.docx 免费下载
版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领
文档简介
1、 HYPERLINK https:/www.MedChemE/Targets/Trk Receptor.html Trk HYPERLINK https:/www.MedChemE/Targets/Trk Receptor.html HYPERLINK https:/www.MedChemE/Targets/Trk Receptor.html ReceptorTropomyosin related kinase receptorTrk receptors are a family of three receptor tyrosine kinases (TrkA, TrkB, and TrkC)
2、, each of which can be activated by one or more of four neurotrophins-nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), and neurotrophins 3 and 4 (NT3 andNT4).TrkA, TrkB, and TrkC are transmembrane proteins that comprise the TRK receptor family. These receptor tyrosine kinases are
3、expressed in human neuronal tissue, and play an essential role in both the physiology of development and function of the nervoussystem through activation by neurotrophins (NTs). The latter are specific ligands known as NGF for TrkA, BDGF, and NT-4/5 for TrkBand NT3 for TrkC, respectively.The binding
4、 of the ligand to the receptor triggers the oligomerisation of the receptors and phosphorylation of specific tyrosineresidues in the intracytoplasmic kinase domain. This event results into the activation of signal transduction pathways leading toproliferation, differentiation and survival in normal
5、and neoplastic neuronal cells.www.MedChemE 1 HYPERLINK https:/www.MedChemE/Targets/Trk Receptor.html Trk HYPERLINK https:/www.MedChemE/Targets/Trk Receptor.html HYPERLINK https:/www.MedChemE/Targets/Trk Receptor.html Receptor HYPERLINK https:/www.MedChemE/Targets/Trk Receptor.html HYPERLINK https:/w
6、ww.MedChemE/Targets/Trk Receptor.html Inhibitors, HYPERLINK https:/www.MedChemE/Targets/Trk Receptor.html HYPERLINK https:/www.MedChemE/Targets/Trk Receptor.html Agonists, HYPERLINK https:/www.MedChemE/Targets/Trk Receptor.html HYPERLINK https:/www.MedChemE/Targets/Trk Receptor.html Activators HYPER
7、LINK https:/www.MedChemE/Targets/Trk Receptor.html HYPERLINK https:/www.MedChemE/Targets/Trk Receptor.html & HYPERLINK https:/www.MedChemE/Targets/Trk Receptor.html HYPERLINK https:/www.MedChemE/Targets/Trk Receptor.html Antagonists HYPERLINK https:/www.MedChemE/r-larotrectinib.html (R)-Larotrectini
8、b(R)-LOXO-101; (R)-ARRY-470) Cat. No.: HY-12866B HYPERLINK https:/www.MedChemE/7,8-Dihydroxyflavone.html 7,8-DihydroxyflavoneCat. No.: HY-W013372(R)-Larotrectinib is a potent TRK inhibitor withan IC value of 28.5 nM for TrkA.50(R)-Larotrectinib can be used for researchingcancer, inflammatory and cer
9、tain infectiousdiseases.7,8-Dihydroxyflavone is a potent and selectiveTrkB agonist that mimics the physiologicalactions of Brain-derived neurotrophic factor(BDNF). Displays therapeutic efficacy towardvarious neurological diseases.Purity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgPurit
10、y: 99.90%Clinical Data: No Development ReportedSize: 10 mM 1 mL, 50 mg HYPERLINK https:/www.MedChemE/Altiratinib.html Altiratinib(DCC-2701) Cat. No.: HY-B0791 HYPERLINK https:/www.MedChemE/amitriptyline-hydrochloride.html Amitriptyline HYPERLINK https:/www.MedChemE/amitriptyline-hydrochloride.html H
11、YPERLINK https:/www.MedChemE/amitriptyline-hydrochloride.html hydrochlorideCat. No.: HY-B0527AAltiratinib (DCC-2701) is a multi-targeted kinaseinhibitor with IC s of 2.7, 8, 9.2, 9.3, 0.85,504.6, 0.83 nM for MET, TIE2, VEGFR2, FLT3,Trk1, Trk2, and Trk3 respectively.Amitriptyline hydrochloride is an
12、inhibitor ofserotonin reuptake transporter (SERT) andnoradrenaline reuptake transporter (NET), with Ksiof 3.45 nM and 13.3 nM for human SERT and NET,respectively.Purity: 98.06%Clinical Data: Phase 1Size: 10 mM 1 mL, 5 mg, 10 mg, 50 mg, 100 mgPurity: 99.56%Clinical Data: LaunchedSize: 10 mM 1 mL, 500
13、 mg, 1 g, 5 g HYPERLINK https:/www.MedChemE/amitriptyline-d3-hydrochloride.html Amitriptyline-d3 HYPERLINK https:/www.MedChemE/amitriptyline-d3-hydrochloride.html HYPERLINK https:/www.MedChemE/amitriptyline-d3-hydrochloride.html hydrochloride HYPERLINK https:/www.MedChemE/amitriptyline-d3-hydrochlor
14、ide.html HYPERLINK https:/www.MedChemE/amitriptyline-d6-hydrochloride.html Amitriptyline-d6 HYPERLINK https:/www.MedChemE/amitriptyline-d6-hydrochloride.html HYPERLINK https:/www.MedChemE/amitriptyline-d6-hydrochloride.html hydrochlorideCat. No.: HY-135096 Cat. No.: HY-B0527ASAmitriptyline-d3 hydroc
15、hloride is the deuteriumlabeled Amitriptyline (hydrochloride).Amitriptyline-d6 hydrochloride is the deuteriumlabeled Amitriptyline hydrochloride.Purity: 98%Clinical Data: No Development ReportedSize: 2.5 mg, 1 mg, 5 mg, 10 mgPurity: 98%Clinical Data: No Development ReportedSize: 2.5 mg, 1 mg, 5 mg,
16、25 mg HYPERLINK https:/www.MedChemE/ANA-12.html ANA-12 HYPERLINK https:/www.MedChemE/ANA-12.html HYPERLINK https:/www.MedChemE/AZ-23.html AZ-23Cat. No.: HY-12497(AZ23; AZ 23) Cat. No.: HY-15590ANA-12 is a potent and selective TrkB antagonistwith IC s of 45.6 nM and 41.1 M for the high and50low affin
17、ity sites, respectively.AZ-23 is an ATP-competitive and orallybioavailable Trk kinase A/B/C inhibitor withIC s of 2 nM (TrkA), 8 nM (TrkB), 24 nM (FGFR1),5052 nM (Flt3), 55 nM (Ret), 84 nM (MuSk), 99 nM(Lck), respectively.Purity: 99.91%Clinical Data: No Development ReportedSize: 10 mM 1 mL, 10 mg, 5
18、0 mgPurity: 98.57%Clinical Data: No Development ReportedSize: 10 mM 1 mL, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg HYPERLINK https:/www.MedChemE/Belizatinib.html Belizatinib HYPERLINK https:/www.MedChemE/Belizatinib.html HYPERLINK https:/www.MedChemE/CE-245677.html CE-245677(TSR-011) Cat. No.: HY-17603Cat.
19、 No.: HY-112423Belizatinib is an oral, dual, potent inhibitor ofALK and TRKA, TRKB, and TRKC, with IC of 0.7nM50for wild-type recombinant ALK kinase.CE-245677 is a potent reversible inhibitor of Tie2and TrkA/B kinases with a cellular IC s of 4.750and 1 nM.Purity: 99.66%Clinical Data: Phase 2Size: 10
20、 mM 1 mL, 2 mg, 5 mg, 10 mg, 25 mg, 50 mg, 100 mgPurity: 98.72%Clinical Data: No Development ReportedSize: 10 mM 1 mL, 5 mg, 10 mg, 50 mg, 100 mg2 Tel: 609-228-6898 Fax: 609-228-5909 Email: salesMedChemE HYPERLINK https:/www.MedChemE/CH7057288.html CH7057288 HYPERLINK https:/www.MedChemE/CH7057288.h
21、tml HYPERLINK https:/www.MedChemE/cyclotraxin-b.html Cyclotraxin HYPERLINK https:/www.MedChemE/cyclotraxin-b.html HYPERLINK https:/www.MedChemE/cyclotraxin-b.html BCat. No.: HY-107362 Cat. No.: HY-P1178CH7057288 is a potent and selective TRKinhibitor.Cyclotraxin B, a cyclic peptide, is a highlypoten
22、t and selective TrkB inhibitor withoutaltering the binding of BDNF. Cyclotraxin Bnon-competitively inhibits BDNF-induced TrkBactivity with an IC of 0.30 nM.50Purity: 98.68%Clinical Data: No Development ReportedSize: 10 mM 1 mL, 5 mg, 10 mg, 25 mg, 50 mg, 100 mgPurity: 99.87%Clinical Data: No Develop
23、ment ReportedSize: 1 mg, 5 mg, 10 mg HYPERLINK https:/www.MedChemE/cyclotraxin-b-tfa.html Cyclotraxin HYPERLINK https:/www.MedChemE/cyclotraxin-b-tfa.html HYPERLINK https:/www.MedChemE/cyclotraxin-b-tfa.html B HYPERLINK https:/www.MedChemE/cyclotraxin-b-tfa.html HYPERLINK https:/www.MedChemE/cyclotr
24、axin-b-tfa.html TFA HYPERLINK https:/www.MedChemE/cyclotraxin-b-tfa.html HYPERLINK https:/www.MedChemE/d5261.html D5261Cat. No.: HY-P1178A Cat. No.: HY-144690Cyclotraxin B TFA, a cyclic peptide, is a highlypotent and selective TrkB inhibitor withoutaltering the binding of BDNF. Cyclotraxin B TFAnon-
25、competitively inhibits BDNF-induced TrkBactivity with an IC of 0.30 nM.50D5261 is a potent, type III allosterictropomyosin-related kinase A (TrkA) inhibitor.Purity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgPurity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg HYPERLINK ht
26、tps:/www.MedChemE/ds-1205b-free-base.html DS-1205b HYPERLINK https:/www.MedChemE/ds-1205b-free-base.html HYPERLINK https:/www.MedChemE/ds-1205b-free-base.html free HYPERLINK https:/www.MedChemE/ds-1205b-free-base.html HYPERLINK https:/www.MedChemE/ds-1205b-free-base.html baseCat. No.: HY-114357A HYP
27、ERLINK https:/www.MedChemE/Entrectinib.html Entrectinib(NMS-E628; RXDX-101) Cat. No.: HY-12678DS-1205b free base is a potent and selectiveinhibitor of AXL kinase, with an IC of 1.3 nM.50DS-1205b free base also inhibits MER, MET,and TRKA, with IC s of 63, 104, and 407 nM,50respectively. DS-1205b free
28、 base can inhibit cellmigration in vitro and tumor growth in vivo.Purity: 99.92%Clinical Data: No Development ReportedSize: 5 mg, 10 mg, 25 mg, 50 mgEntrectinib (NMS-E628) is a potent, orallyavailable, and CNS-active pan-Trk, ROS1, andALK inhibitor. Entrectinib inhibits TrkA, TrkB,TrkC, ROS1 and ALK
29、 with IC values of 1, 3, 5, 1250and 7 nM, respectively. Antitumor activity.Purity: 99.32%Clinical Data: LaunchedSize: 10 mM 1 mL, 5 mg, 10 mg, 50 mg, 100 mg HYPERLINK https:/www.MedChemE/flt3-trka-in-1.html FLT3/TrKA-IN-1 HYPERLINK https:/www.MedChemE/flt3-trka-in-1.html HYPERLINK https:/www.MedChem
30、E/GNF-5837.html GNF-5837Cat. No.: HY-146749 Cat. No.: HY-13491FLT3/TrKA-IN-1 is a potent FLT3/TrKA dual kinaseinhibitor with the IC s of 43.8 nM, 97.2 nM, 92.550nM and 23.6 nM for FLT3, FLT3-ITD, FLT3-TKD andTrKA, respectively.GNF-5837 is a potent, selective, and orallybioavailable pan-tropomyosin r
31、eceptor kinase(TRK) inhibitor which display antiproliferativeeffects in cellular Ba/F3 assays ( IC values of507 nM, 9 nM and 11 nM for cells containing thefusion proteins Tel-TrkC, Tel-TrkB andPurity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgPurity: 99.45%Clinical Data: No Developmen
32、t ReportedSize: 10 mM 1 mL, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg HYPERLINK https:/www.MedChemE/gnf-8625-monopyridin-n-piperazine-hydrochloride.html GNF-8625 HYPERLINK https:/www.MedChemE/gnf-8625-monopyridin-n-piperazine-hydrochloride.html HYPERLINK https:/www.MedChemE/gnf-8625-monopyridin-n-piperazine
33、-hydrochloride.html monopyridin-N-piperazine HYPERLINK https:/www.MedChemE/gnf-8625-monopyridin-n-piperazine-hydrochloride.html HYPERLINK https:/www.MedChemE/gnf-8625-monopyridin-n-piperazine-hydrochloride.html hydrochloride HYPERLINK https:/www.MedChemE/gnf-8625-monopyridin-n-piperazine-hydrochlori
34、de.html HYPERLINK https:/www.MedChemE/GW-441756.html GW HYPERLINK https:/www.MedChemE/GW-441756.html HYPERLINK https:/www.MedChemE/GW-441756.html 441756Cat. No.: HY-131706A Cat. No.: HY-18314GNF-8625 monopyridin-N-piperazine hydrochloride(TRKi-2), a TRK inhibitor, which is from thepatent WO 20200384
35、15 A1.GW 441756 is a potent and specific nerve growthfactor (NGF) receptor tyrosine kinases A (TrkA)inhibitor (IC =2 nM), which eliminates the BmK50NSPK-induced neurite outgrowth.Purity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgPurity: 98.65%Clinical Data: No Development ReportedSize
36、: 10 mM 1 mL, 10 mg, 50 mgwww.MedChemE 3 HYPERLINK https:/www.MedChemE/htrka-in-1.html hTrkA-IN-1 HYPERLINK https:/www.MedChemE/htrka-in-1.html HYPERLINK https:/www.MedChemE/ihmt-trk-284.html IHMT-TRK-284Cat. No.: HY-136535 Cat. No.: HY-146697hTrkA-IN-1 is a potent and orally active inhibitorof TrkA
37、 kinase with an IC of 1.3 nM, compound 2.50extracted from patent WO2015175788. hTrkA-IN-1 canbe used for the study of inflammatory disease,such as prostatitis, pelvic, et al.IHMT-TRK-284 (Compound 34) is a potent, orallyactive type II TRK kinase inhibitor with IC50values of 10.5, 0.7, and 2.6 nM to
38、TRKA, B, andC respectively. IHMT-TRK-284 displays greatselectivity profile in the kinome and good in vivoantitumor efficacies.Purity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgPurity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg HYPERLINK https:/www.MedChemE/k-252a.html K
39、-252a(SF2370; Antibiotic K 252a; Antibiotic SF 2370) Cat. No.: HY-N6732 HYPERLINK https:/www.MedChemE/LOXO-101.html Larotrectinib(LOXO-101; ARRY-470) Cat. No.: HY-12866K-252a, a staurosporine analog, inhibits proteinkinase, with IC values of 470 nM, 140 nM, 270 nM,50and 1.7 nM for PKC, PKA,Ca2+/calm
40、odulin-dependent kinase type II, andphosphorylase kinase, respectively.Larotrectinib (LOXO-101) is an ATP-competitiveoral, selective inhibitor of thetropomyosin-related kinase (TRK) familyreceptors, with low nanomolar 50% inhibitoryconcentrations against all three isoforms (TRKA,B, and C).Purity: 99
41、.45%Clinical Data: No Development ReportedSize: 10 mM 1 mL, 1 mg, 5 mgPurity: 99.93%Clinical Data: LaunchedSize: 10 mM 1 mL, 5 mg, 10 mg, 50 mg, 100 mg HYPERLINK https:/www.MedChemE/LOXO-101-sulfate.html Larotrectinib HYPERLINK https:/www.MedChemE/LOXO-101-sulfate.html HYPERLINK https:/www.MedChemE/
42、LOXO-101-sulfate.html sulfate(LOXO-101 sulfate; ARRY-470 sulfate) Cat. No.: HY-12866A HYPERLINK https:/www.MedChemE/larotrectinib-d7.html Larotrectinib-d7(LOXO-101-d7; ARRY-470-d7) Cat. No.: HY-12866SLarotrectinib sulfate (LOXO-101 sulfate; ARRY-470sulfate) is an ATP-competitive oral, selectiveinhib
43、itor of the tropomyosin-related kinase (TRK)family receptors, with low nanomolar 50%inhibitory concentrations against all threeisoforms (TRKA, B, and C).Larotrectinib-d7 (LOXO-101-d7) is the deuteriumlabeled Larotrectinib.Purity: 99.57%Clinical Data: LaunchedSize: 10 mM 1 mL, 5 mg, 10 mg, 50 mg, 100
44、 mgPurity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg HYPERLINK https:/www.MedChemE/Lestaurtinib.html Lestaurtinib HYPERLINK https:/www.MedChemE/Lestaurtinib.html HYPERLINK https:/www.MedChemE/LM22A-4.html LM22A-4(CEP-701; KT-5555) Cat. No.: HY-50867Cat. No.: HY-100673Lestaurtinib (CE
45、P-701;KT-5555) is anATP-competitive multi-kinase inhibitor with potentactivity against the Trk family of receptortyrosine kinases. Lestaurtinib inhibits JAK2,FLT3 and TrkA with IC s of 0.9, 3 and less than5025 nM, respectively.LM22A-4 is a specific agonist of tyrosine kinasereceptor B, used for neur
46、ological diseaseresearch.Purity: 99.92%Clinical Data: Phase 3Size: 5 mgPurity: 98.0%Clinical Data: No Development ReportedSize: 10 mM 1 mL, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg HYPERLINK https:/www.MedChemE/LM22B-10.html LM22B-10 HYPERLINK https:/www.MedChemE/LM22B-10.html HYPERLINK https:/www.MedChemE
47、/lpm4870108.html LPM4870108Cat. No.: HY-104047 Cat. No.: HY-132229LM22B-10 is an activator of TrkB/TrkCneurotrophin receptor, and can induce TrkB,TrkC, AKT and ERK activation in vitro and invivo.Purity: 99.72%Clinical Data: No Development ReportedSize: 10 mM 1 mL, 2 mg, 5 mg, 10 mg, 50 mg, 100 mgLPM
48、4870108 is a potent and orally active pan-Trk(WT and MT) inhibitor, with IC s of 0.2 nM,502.4 nM, 3.5 nM and 2.3 nM for TrkC, TrkA,TrkAG595R and TrkAG667C, respectively.LPM4870108 shows selectivity for Trk over ALK(IC =182 nM).50Purity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg4 Tel:
49、 609-228-6898 Fax: 609-228-5909 Email: salesMedChemE HYPERLINK https:/www.MedChemE/N-Acetyl-5-hydroxytryptamine.html N-Acetyl-5-hydroxytryptamine(N-Acetylserotonin; Normelatonin; O-Demethylmelatonin) Cat. No.: HY-107854 HYPERLINK https:/www.MedChemE/n-acetyl-5-hydroxytryptamine-d3.html N-Acetyl-5-hy
50、droxytryptamine-d3 HYPERLINK https:/www.MedChemE/n-acetyl-5-hydroxytryptamine-d3.html (N-Acetylserotonin-d3;Normelatonin-d3; O-Demethylmelatonin-d3) Cat. No.: HY-107854SN-Acetyl-5-hydroxytryptamine is a Melatoninprecursor, and that it can potently activate TrkBreceptor.N-Acetyl-5-hydroxytryptamine-d
51、3(N-Acetylserotonin-d3) is the deuterium labeledN-Acetyl-5-hydroxytryptamine.N-Acetyl-5-hydroxytryptamine is a Melatoninprecursor, and that it can potently activate TrkBreceptor.Purity: 99.90%Clinical Data: No Development ReportedSize: 10 mM 1 mL, 50 mgPurity: 98%Clinical Data: No Development Report
52、edSize: 1 mg, 5 mg HYPERLINK https:/www.MedChemE/ono-7475.html ONO-7475 HYPERLINK https:/www.MedChemE/ono-7475.html HYPERLINK https:/www.MedChemE/paltimatrectinib.html PaltimatrectinibCat. No.: HY-114358 Cat. No.: HY-145587ONO-7475 is a potent, selective, and orally activeAxl/Mer inhibitor with IC v
53、alues of 0.7 nM50and 1.0 nM, respectively. ONO-7475 sensitizesAXL-overexpressing EGFR-mutant NSCLC cells tothe EGFR-TKIs, suppresses the emergence andmaintenance of tolerant cells.Paltimatrectinib (compound I-147) is a potenttyrosine kinase inhibitor with an IC of 98%Clinical Data: No Development Re
54、portedSize: 1 mg, 5 mg HYPERLINK https:/www.MedChemE/pan-trk-in-2.html Pan-Trk-IN-2 HYPERLINK https:/www.MedChemE/pan-trk-in-2.html HYPERLINK https:/www.MedChemE/pan-trk-in-3.html Pan-Trk-IN-3Cat. No.: HY-144028 Cat. No.: HY-144069Compound cpd-1 is a small molecule Trks inhibitorwith good antitumor
55、activity.Pan-Trk-IN-3 (Compound 11g) is a potent inhibitorof pan-Trk and their drug-resistant mutants withIC values of 2, 3, 2, 21, 26, 5, 7 and 6 nM50against TrkA, TrkB, TrkC, TrkAG595R,TrkAG667C, TrkAG667S, TrkAF589L andTrkCG623R, respectively.Purity: 98%Clinical Data: No Development ReportedSize:
56、 1 mg, 5 mgPurity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg HYPERLINK https:/www.MedChemE/pf-06273340.html PF-06273340 HYPERLINK https:/www.MedChemE/pf-06273340.html HYPERLINK https:/www.MedChemE/Trk-IN-3.html PF-06733804Cat. No.: HY-122616 Cat. No.: HY-112434PF-06273340 is a potent
57、, selective, orallybioavailable and peripherally restricted pan Trkinhibitor.PF-06733804 is a potent pan-Trk inhibitor incell-based assays with IC s of 8.4 nM, 6.2 nM and502.2 nM for TrkA, TrkB and TrkC, respectively.Anti-hyperalgesic effect.Purity: 98%Clinical Data: No Development ReportedSize: 1 m
58、g, 5 mgPurity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg HYPERLINK https:/www.MedChemE/Trk-IN-5.html PF-06737007 HYPERLINK https:/www.MedChemE/Trk-IN-5.html HYPERLINK https:/www.MedChemE/Trk-IN-4.html PF-6683324Cat. No.: HY-112437(Trk-IN-4) Cat. No.: HY-112436PF-06737007 is a potent
59、pan-Trk inhibitor incell-based assays with IC s of 7.7 nM, 15 nM and503.9 nM for TrkA, TrkB and TrkC, respectively.Anti-hyperalgesic effect.PF-6683324 (Trk-IN-4) is a potent pan-Trkinhibitor in cell-based assays with IC s of 1.950nM, 2.6 nM and 1.1 nM for TrkA, TrkB and TrkC,respectively. Anti-hyper
60、algesic effect.Purity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgPurity: 98%Clinical Data: No Development ReportedSize: 5 mg, 10 mg, 25 mg, 50 mg, 100 mgwww.MedChemE 5 HYPERLINK https:/www.MedChemE/TPX-0005.html Repotrectinib(TPX-0005) Cat. No.: HY-103022 HYPERLINK https:/www.MedChemE
温馨提示
- 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
- 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
- 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
- 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
- 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
- 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
- 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。
最新文档
- 2025年度冰淇淋品牌代理经营数据监测与分析合同
- 2025年度高科技农业项目垫资合同样本
- 2025年度纯净水电商平台运营合作协议范本
- 2025年度网络安全风险评估与整改合同
- 医院文化建设宣传与落实方案计划
- 小班社会性技能培养计划
- 完美家庭学期班级家庭教育计划
- 优化项目周期管理的工作总结计划
- 制定多层次绩效激励方案计划
- 2025年金属制卫生、烹饪、餐饮器具项目建议书
- 页眉和页脚基本知识课件
- 《卖火柴的小女孩》的语文说课课件
- ST语言编程手册
- 经济数学基础(高职)全套教学课件
- 员工工作失误给公司造成损失赔偿的制度
- 世界教育思想文库:我们如何学习:全视角学习理论
- 石材幕墙维修方案
- 《数字经济学》 课件 贾利军 专题3:数字时代下社会总资本再生产研究;专题4:数字货币与数字金融研究
- 中小学音乐课上的合唱训练
- 《国有企业采购操作规范》【2023修订版】
- 人工智能导论-课件 第1章 人工智能的前世今生
评论
0/150
提交评论